The independent source for health policy research, polling, and news.
6,261 - 6,280 of 15,253 Results
More than 275 people — mostly in Orthodox Jewish communities — have been infected since the disease began spreading in October. That’s about half of the confirmed cases in 11 states that were reported nationwide by the federal officials since January 2018.
The FDA said it might reclassify the widely used devices featured in a recent Kaiser Health News investigation.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Millennials and Gen Zers say they often feel isolated even when surrounded by friends — both real and virtual.
Most hospitals appear to be complying with the federal rule to post their prices online. Yet there is little follow-up by the government or industry and debate continues about whether the price lists are creating more confusion than clarity among consumers.
Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the resignation of Food and Drug Administration Commissioner Scott Gottlieb, the latest on federal and state efforts to shore up the Affordable Care Act; and how public health officials plan to persuade parents who are reluctant to vaccinate their kids. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.
The Food and Drug Administration has let medical device companies file reports of injuries and malfunctions outside a widely scrutinized public database, leaving doctors and medical sleuths in the dark.
A recent outbreak at a Louisiana center triggered public health protections, but some immigration lawyers are crying foul.
The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.
The Golden State, in a movement spearheaded by its first-ever surgeon general, stands to become a vanguard for the nation in tracing adverse childhood experiences, or ACEs, to the onset of physical and mental illness. But what can a pediatrician, with her 15-minute time slots and extensive to-do list, do about the ills of an absent parent or a neighborhood riddled with gun violence?
Doctors and patients say they’re compelled to use off-label meds as research goes unfunded.
High-profile failures of implantable medical devices — such as certain hip joints and pelvic mesh — have prompted the Food and Drug Administration to revise its assessment process.
New research shows how an experience with surprise medical bills can guide patients’ future decision-making.
A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.
A proposed state law with bipartisan, bicameral support is on the move in Texas. It would force hospitals and insurers to settle surprise bills — instead of relying on patients to start the mediation process. The KHN/NPR "Bill of the Month" series is a catalyst for the effort.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
The penalties are part of a program set up by the Affordable Care Act to prompt hospitals to pay more attention to safety issues that can lead to injuries, such as falls or hospital-acquired infections.
© 2026 KFF